In the latest episode of consulting company Cell One Partners’ video series—Cell One Insights—on cell and gene therapy, Stephen Chang, PhD—a human geneticist and partner at Cell One Partners—shares insights from his 40...
Iovance Biotherapeutics (NASDAQ: IOVA) has announced the appointment of Corleen Roche as chief financial officer (CFO), effective August 6, 2025. Ms. Roche brings three decades of biotech and life sciences industry...
BiomX (NYSE: PHGE) has announced the initiation of patient dosing in its Phase 2b trial evaluating BX004 for the treatment of cystic fibrosis (CF) patients with chronic pulmonary infections caused by Pseudomonas...
Closely held EsoBiotec is transforming cell therapy by engineering immune cells directly within a patient’s body, enabling the immune system to attack disease—potentially delivering cell therapy to patients in minutes...
Firefly Neuroscience (NASDAQ: AIFF) has announced its continued collaboration with Prof. Christian Schaaf, MD, Director of the Institute of Human Genetics at Heidelberg University Hospital and Chairman of Human Genetics...
MiNK Therapeutics (NASDAQ: INKT) has highlighted a publication in the peer-reviewed journal Oncogene describing a complete and durable remission in a patient with metastatic, treatment refractory testicular cancer...
Quince Therapeutics (NASDAQ: QNCX) has announced the appointment of leading immunologist, Hassan Abolhassani, MD, PhD, to its scientific advisory board (SAB). Dr. Abolhassani currently serves as assistant professor of...
Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855) has announced that China’s National Medical Products Administration (NMPA) has approved its proprietary novel Bcl-2 selective inhibitor lisaftoclax (APG-2575) for the...
Closely held PharmaJet has announced the signing of a Memorandum of Understanding (MOU) with the Egyptian Unified Procurement Authority (UPA) and closely held EVA Pharma. The agreement aims to explore the integration of...
Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855) has announced the appointment of Veet Misra, PhD, as chief financial officer (CFO), and Eric Huang as senior vice president (SVP) of global corporate development and...